Brief: Anixa Biosciences Announces Timing Of Public Release Of Data From The Phase 1 Study Of Its Breast Cancer Vaccine
06/11/2024 13:32
Nov 6 (Reuters) - Anixa Biosciences Inc ANIX.O :
* ANIXA BIOSCIENCES ANNOUNCES TIMING OF PUBLIC RELEASE OF
DATA
FROM THE PHASE 1 STUDY OF ITS BREAST CANCER VACCINE AT THE 39TH
SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) ANNUAL MEETING
* ANIXA BIOSCIENCES INC - TO RELEASE PHASE 1 BREAST CANCER
VACCINE
DATA ON NOV 8
Source text: ID:nPnbJFxmNa
Further company coverage: ANIX.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Anixa Biosciences
See all newsBrief: Anixa Biosciences Announces First Case Of Stable Disease For Three Months In Ovarian Cancer Car-T Clinical Trial
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary
Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine